Skip to main content
Loading…

Chamber and committees

The Lobular Moon Shot Project, Raising Awareness of Lobular Breast Cancer and the Lack of Research

  • Submitted by: David Barratt, Cowdenbeath, Scottish National Party
  • Date lodged: Thursday, 28 May 2026
  • Motion type: Members' Business Motion
  • Motion reference: S7M-00179
  • Current status: Has not yet achieved cross-party support

That the Parliament recognises the work of the Lobular Moon Shot Project in raising awareness of invasive lobular breast cancer; notes that this condition is the second most common type of breast cancer, accounting for around 15% of diagnoses, with an average of 22 women a day in the UK receiving a lobular diagnosis, yet it is often considered to have been historically under-researched and underfunded; understands that it presents and behaves differently from other forms of breast cancer, often not forming a distinct lump and therefore being more difficult to detect through routine screening; believes that there are currently no treatments specifically developed for the condition, despite its distinct biological characteristics; notes with concern that less than 1% of breast cancer research funding has historically been directed towards lobular research; recognises calls from the Lobular Moon Shot Project for dedicated investment in research into its basic biology, including proposals for £20 million of ring-fenced funding from the UK Government over five years; welcomes the involvement of researchers from Scottish institutions, alongside the Manchester Breast Centre and international partners; believes that improved understanding of lobular breast cancer could lead to earlier diagnosis, more targeted treatments and better long-term outcomes for women living with the condition in Cowdenbeath and across the country, while reducing pressures on the NHS, and notes calls urging the Scottish Government to support the aims of the Lobular Moon Shot Project and to press the UK Government to commit the funding required to ensure that women diagnosed with lobular breast cancer can benefit from equitable research, treatment and care.